You have 9 free searches left this month | for more free features.

City

Seoul (1)

Condition

Metastatic ALK+ Non Small Cell Lung Cancer (1)

Overall Status

Not yet recruiting (1)

Sign in for free

Phase

Sponsor

Pfizer (1)

Collaborator

Intervention

lorviqua (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Observational (1)

lorviqua

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Post Marketing Surveillance(PMS) Study of Lorviqua in Korea

Not yet recruiting

Metastatic ALK+ Non Small Cell Lung Cancer

Lorviqua

Seoul, Korea, Republic of

Pfizer

Jan 24, 2023